This inventor holds 1 USPTO granted patent. Top assignee: Cordis Corporation. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Howard Ira Amols: Innovator in Radioactive Seed Technology
Introduction
Howard Ira Amols is a notable inventor based in Bronx, NY (US). He has made significant contributions to the field of medical technology, particularly in the development of low attenuating radioactive seeds. His innovative approach aims to enhance therapeutic efficacy in clinical treatments.
Latest Patents
Amols holds a patent for a low attenuation radioactive seed. This invention utilizes a core with a fluted or non-circular cross section to increase the dose rate, decrease dwell times, and improve clinical outcomes. The design enhances the surface area for the deposition of the radioactive substance, thereby increasing the therapeutic efficacy of the seed. Additionally, the unique core design reduces photon emission attenuation, allowing for more effective treatment delivery.
Career Highlights
Amols is associated with Cordis Corporation, where he applies his expertise in medical technology. His work focuses on advancing treatment options that improve patient outcomes through innovative design and engineering.
Collaborations
Some of his coworkers include Benjamin David McDaniel and Michael Dennis O'Hara, who contribute to the collaborative efforts in developing cutting-edge medical technologies.
Conclusion
Howard Ira Amols stands out as an inventor dedicated to improving medical treatments through innovative technologies. His work on low attenuating radioactive seeds exemplifies the impact of inventive thinking in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile